• Infrastructure
• Online Safety
• Policy Engagement

Brain Canada along with Heart & Stroke and the Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health (CIHR-ICRH), are excited to launch the Personnel Awards for Black Scholars. The objective of the competition is to increase the number of highly qualified Black trainees across Canada committed to working in the fields of heart and brain research. 

By investing in Black researchers, we hope to strengthen representation in the Canadian research community.  

This opportunity aims at establishing and advancing promising early career investigators from across Canada with a focused commitment to undertaking cancer research. Through the CCS Emerging Scholar Research Grants, early career investigators will develop their cancer research programs in Canada and pursue important scientific advances of the highest quality and potential for impact in the four pillars of health research (biomedical; clinical; health services; and social, cultural, environmental & population health).

The purpose of the PRAs is to identify and support emerging researchers with interest in furthering knowledge on social and emotional skills (SES) and the future of work.

For more information, please click here.

Each year, RSRPP funds researchers across Ontario to study key road safety challenges and develop novel and actionable ways to make Ontario's roads safer. RSRPP projects take on average between one to three years to complete and typically do not exceed $50,000 per year in program funding. Selected partners must conduct applied road safety research using methodologies that the Ministry of Transportation cannot perform internally. This includes research that leverages any form of specialized equipment or resources such as private data sources, survey studies, simulator testing, or clinical expertise, as examples. Only studies that cannot be performed by MTO personnel are eligible for program funding.

Guidelines

Application Form

Brain Canada and ALS Canada share a strong belief that it is crucial that promising young investigators are nurtured in the early stages of their careers so they can strive to promote discovery and advancement.

The intent for this award is to attract the brightest young minds to ALS research, which will contribute to a succession plan for the Canadian ALS research community. This program is designed to nurture and support innovative ideas and compelling breakthroughs across the spectrum of ALS research.

A $315,000 pool of funds will be available for this program. Each Doctoral Award would be funded at $25,000 per year for up to three years, and each Postdoctoral Fellowship would be funded at $55,000 per year for up to three years. The funds awarded through this fellowship will be utilized to support the stipend/salary of the awardee(s).

CQDM’s Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. Projects selected as part of the Quantum Leap program focus on developing cutting-edge technologies with the potential to significantly advance the R&D activities of CQDM’s pharmaceutical members. Quantum Leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members.

The enabling technologies, innovative platforms and/or innovative therapies derived from the Quantum Leap pharma-led funding program for drug discovery research are selected for their potential to significantly improve, facilitate and/or accelerate the drug discovery process and the development of safer and more effective drugs. The technologies of interest can be at any stage of the drug development process and involve a wide range of therapeutic indications.

Projects are associated with specific deliverables and must be ready for use by CQDM pharmaceutical members upon completion. For scientists, the funded research opens new collaboration opportunities with world-class stakeholders in the industry.